Garret Ma1, Idris Samad2, Kevin Motz2, Linda X Yin2, Madhavi V Duvvuri2, Dacheng Ding2, Daryan R Namba2, Jennifer H Elisseeff1, Maureen R Horton3, Alexander T Hillel2. 1. Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A. 2. Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A. 3. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A.
Abstract
OBJECTIVES/HYPOTHESIS: Laryngotracheal stenosis (LTS) is a chronic fibrotic disease characterized by fibroblast proliferation, collagen deposition, and matrix remodeling in the lamina propria of the larynx and/or trachea. Current medical therapies are limited by a poor understanding of the effector cell's (fibroblasts) cellular biology and metabolism. The purpose of this study was to compare cellular proliferation, function, and metabolism between normal and LTS-derived fibroblasts in vitro. We hypothesize that LTS-derived fibroblasts will demonstrate aberrant behavior with faster proliferation, increased collagen production, and altered metabolic allocation compared with normal fibroblasts. STUDY DESIGN: In vitro comparative analysis. METHODS: Human biopsies of normal and iatrogenic LTS tissue (n = 7) were obtained, and fibroblasts were isolated and cultured in vitro. Cellular proliferation, cellular histology, gene expression, and metabolic analyses were performed. Statistical analyses comparing normal and scar-derived fibroblasts were performed. RESULTS: LTS fibroblast proliferation rate, cellular surface area, and collagen-1 expression were increased compared to normal fibroblasts. Cellular metabolic analysis of LTS-derived fibroblasts demonstrated reduced oxidative phosphorylation and increased glycolysis/oxidative phosphorylation ratio compared with normal fibroblasts. CONCLUSIONS: Human iatrogenic LTS-derived fibroblasts demonstrated aberrant behavior when compared with normal fibroblasts. A Warburg-like effect was revealed, suggesting human iatrogenic LTS fibroblasts drive their proliferation with aerobic glycolysis. The distinct metabolism suggests metabolic inhibitors could reduce fibroblast hyperplasia and hypertrophy in LTS and fibrosis in general. LEVEL OF EVIDENCE: NA Laryngoscope, 127:E107-E113, 2017.
OBJECTIVES/HYPOTHESIS: Laryngotracheal stenosis (LTS) is a chronic fibrotic disease characterized by fibroblast proliferation, collagen deposition, and matrix remodeling in the lamina propria of the larynx and/or trachea. Current medical therapies are limited by a poor understanding of the effector cell's (fibroblasts) cellular biology and metabolism. The purpose of this study was to compare cellular proliferation, function, and metabolism between normal and LTS-derived fibroblasts in vitro. We hypothesize that LTS-derived fibroblasts will demonstrate aberrant behavior with faster proliferation, increased collagen production, and altered metabolic allocation compared with normal fibroblasts. STUDY DESIGN: In vitro comparative analysis. METHODS:Human biopsies of normal and iatrogenic LTS tissue (n = 7) were obtained, and fibroblasts were isolated and cultured in vitro. Cellular proliferation, cellular histology, gene expression, and metabolic analyses were performed. Statistical analyses comparing normal and scar-derived fibroblasts were performed. RESULTS:LTS fibroblast proliferation rate, cellular surface area, and collagen-1 expression were increased compared to normal fibroblasts. Cellular metabolic analysis of LTS-derived fibroblasts demonstrated reduced oxidative phosphorylation and increased glycolysis/oxidative phosphorylation ratio compared with normal fibroblasts. CONCLUSIONS:Human iatrogenic LTS-derived fibroblasts demonstrated aberrant behavior when compared with normal fibroblasts. A Warburg-like effect was revealed, suggesting human iatrogenic LTS fibroblasts drive their proliferation with aerobic glycolysis. The distinct metabolism suggests metabolic inhibitors could reduce fibroblast hyperplasia and hypertrophy in LTS and fibrosis in general. LEVEL OF EVIDENCE: NA Laryngoscope, 127:E107-E113, 2017.
Authors: Chih-Hao Chang; Jonathan D Curtis; Leonard B Maggi; Brandon Faubert; Alejandro V Villarino; David O'Sullivan; Stanley Ching-Cheng Huang; Gerritje J W van der Windt; Julianna Blagih; Jing Qiu; Jason D Weber; Edward J Pearce; Russell G Jones; Erika L Pearce Journal: Cell Date: 2013-06-06 Impact factor: 41.582
Authors: Alexander T Hillel; Selmin Karatayli-Ozgursoy; James R Benke; Simon Best; Paulette Pacheco-Lopez; Kristine Teets; Heather Starmer; Lee M Akst Journal: Ann Otol Rhinol Laryngol Date: 2014-12-17 Impact factor: 1.547
Authors: Kevin Motz; Idris Samad; Linda X Yin; Michael K Murphy; Madhavi Duvvuri; Dacheng Ding; Alexander T Hillel Journal: JAMA Otolaryngol Head Neck Surg Date: 2017-11-01 Impact factor: 6.223
Authors: Linda X Yin; Kevin M Motz; Idris Samad; Madhavi Duvvuri; Michael Murphy; Dacheng Ding; Alexander T Hillel Journal: Otolaryngol Head Neck Surg Date: 2017-03-28 Impact factor: 3.497
Authors: Michael K Murphy; Kevin M Motz; Dacheng Ding; Linda Yin; Madhavi Duvvuri; Michael Feeley; Alexander T Hillel Journal: Laryngoscope Date: 2017-09-20 Impact factor: 3.325
Authors: Madhavi Duvvuri; Kevin Motz; Michael Murphy; Michael Feeley; Dacheng Ding; Andrew Lee; Jennifer H Elisseeff; Alexander T Hillel Journal: Biomater Sci Date: 2019-04-23 Impact factor: 6.843
Authors: Hsiu-Wen Tsai; Kevin M Motz; Dacheng Ding; Ioan Lina; Michael K Murphy; Dimitri Benner; Michael Feeley; Jody Hooper; Alexander T Hillel Journal: Laryngoscope Date: 2020-01-06 Impact factor: 3.325
Authors: Hsiu-Wen Tsai; Ioan Lina; Kevin M Motz; Liam Chung; Dacheng Ding; Michael K Murphy; Michael Feeley; Jennifer H Elisseeff; Alexander T Hillel Journal: Laryngoscope Date: 2021-01-12 Impact factor: 2.970
Authors: Kevin Motz; Ioan Lina; Michael K Murphy; Virginia Drake; Ruth Davis; Hsiu-Wen Tsai; Michael Feeley; Linda X Yin; Dacheng Ding; Alexander Hillel Journal: Laryngoscope Date: 2020-08-17 Impact factor: 3.325
Authors: Ioan A Lina; Alexandra Berges; Rafael Ospino; Ruth J Davis; Kevin M Motz; Hsiu-Wen Tsai; Samuel Collins; Alexander T Hillel Journal: Otolaryngol Head Neck Surg Date: 2021-06-15 Impact factor: 3.497
Authors: Ioan Lina; Hsiu-Wen Tsai; Dacheng Ding; Ruth Davis; Kevin M Motz; Alexander T Hillel Journal: Laryngoscope Date: 2020-08-28 Impact factor: 2.970